Investor Presentation Full Year 2021
26
Investor presentation Full year 2021
Sales growth of 14% at CER, driven by IO sales growth of 14%
and 14% sales growth in NAO
Historic and reported sales by geography
Sales in DKK billion
Reported sales and growth breakdown
for the full year 2021
Novo NordiskⓇ
107.9
126.9
140.8
Regions
Sales
(mDKK)
Growth
Share of
growth
8%
14%
14%
9%
International Operations
73,537
14%
51%
11%
11%
EMEA
37,706
12%
23%
30%
27%
27%
Region China
16,019
11%
9%
ROW
19,812
19%
19%
North America Operations
67,263
14%
49%
53%
48%
48%
Here of USA
63,009
13%
44%
Total sales
140,800
14%
100%
2015
North America
2020
2021
EMEA
Region China
RoW
IO: International Operations; NAO: North American Operations; EMEA: Europe, Middle East, and Africa; Row: Rest of World; Region China covers mainland China, Hong Kong and Taiwan.
Note: Numbers may not add up to 100% due to rounding; Growth at Constant exchange rates; Sales numbers are reported in Danish kronerView entire presentation